Hybrid Metabolomics Now Standardized

Kit-Based Quantitation & Discovery in One Run

What is it?

Biognosys Group and Bruker introduce the next-generation hybrid workflow that combines quantitative targeted metabolomics with untargeted discovery in a single experiment,
integrating:

Confident discovery with Bruker’s timsMetabo
Robust quantitation with the biocrates MxQuant kit
Streamlined workflow in an integrated software ecosystem

Unlock the Full Potential of Your timsMetabo Platform

Apply for our Early Access Program to gain exclusive pre-launch access to the new Hybrid Metabolomics Workflow.

Please note: The Hybrid Metabolomics Workflow is currently under development and is exclusively available for the Bruker timsMetabo mass spectrometer.

Apply for Early Access Program

Join our Webinar

Game-changing Technology.

Unlimited Coverage.

Instant Insights.

The hybrid workflow combines the strengths of both approaches.

Broader Metabolite Coverage

Targeted quantification + untargeted discovery in one workflow

Increased Efficiency

One instrument, one acquisition – reducing time, effort, and complexity

Lower Resource Requirements

Reduced sample consumption, personnel needs, and overall costs

Actionable Results

From comprehensive data to immediate biological insight

Hybrid Workflow Scheme

Powered by Bruker’s timsMetabo and PASEF technology

Leveraging advanced PASEF technology, the workflow maximizes analytical depth and confident annotation while maintaining high sensitivity and throughput.

Access biomarker discovery and validation within the same analysis, eliminating the traditional separation between targeted and untargeted measurement.
Drive innovation by joining our Early Access Program.